Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+66,500→ 66,500 totalExercise: $45.28Exp: 2033-02-13→ Common Stock (66,500 underlying)
Footnotes (1)
- [F1]The securities awarded on February 13, 2023 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 16,625 shares of common stock shall vest on the one year anniversary of February 13, 2023, with 49,875 shares vesting in 36 equal monthly installments thereafter.